Big pharma, Insight journal - Dealtalk

Abbott Fills Out Leadership Team for its spin-off pharmaceutical comapny, AbbVie

Posted on 05 June 2012

Tags: , , , ,

Abbott Laboratories, a big pharmaceutical company unveiled the leadership team for the  proprietary pharmaceutical division that it plans to separate into an  independent company.

The big pharmaceutical company Abbott had previously disclosed that Richard A. Gonzalez, the 57-year-old  leader of Abbott's pharmaceutical business, will serve as chairman and chief  executive of the new pharmaceutical company, AbbVie, which Abbott plans to establish via a  tax-free distribution of AbbVie shares to Abbott shareholders by the end of this  year.

Abbott Labs disclosed in a filing Monday with the U.S. Securities and  Exchange Commission that it is tapping other in-house executives to go with Mr.  Gonzalez to lead AbbVie.

They include William J. Chase, 44, who will serve as the pharmaceutical company AbbVie's chief financial  officer; he is currently vice president of licensing and acquisitions at Abbott  Laboratories.

Abbott Laboratories' general counsel, Laura J. Schumacher, 48, will take the  same position at AbbVie. AbbVie will name John M. Leonard as senior vice  president of pharmaceutical research and development. Dr. Leonard currently  holds the same position at Abbott.

Also, AbbVie will name Carlos Alban as senior vice president of proprietary  pharmaceutical products, global commercial operations, the same position he  holds at Abbott Labs. Timothy J. Richmond, currently divisional vice president  of compensation and benefits at Abbott Labs, will serve as chief human resources  officer at AbbVie.

Abbott also disclosed compensation for some of the top officers of  AbbVie.

Read the full article at Fox Business  (link no longer working)

 

Related

Read: more on dealtalk in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Report: Partnering Deals and Alliances with Abbott Laboratories

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new1gif
rauconbadgejpg
e78banner300x150animgif